Post-marketing liver injury reports lead to Tysabri PI update


Liver injury warnings added to natalizumab prescribing information.

Reports of markedly elevated serum hepatic enzymes and elevated total bilirubin in patients receiving natalizumab (

Related Videos
fake news misinformation | Image Credit: Bits and Splits -
© 2024 MJH Life Sciences

All rights reserved.